HC Wainwright Issues Pessimistic Forecast for United States Antimony (NYSE:UAMY) Stock Price

United States Antimony (NYSE:UAMY) had its price objective dropped by research analysts at HC Wainwright from $9.25 to $6.50 in a research note issued on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright‘s price target indicates a potential upside of 108.20% from the company’s current price.

Several other research analysts also recently weighed in on UAMY. Texas Capital upgraded United States Antimony to a “strong-buy” rating in a research note on Wednesday, October 7th. Weiss Ratings restated a “sell (d-)” rating on shares of United States Antimony in a research note on Monday, September 14th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $8.75.

United States Antimony Price Performance

Shares of NYSE:UAMY traded up $0.21 on Friday, reaching $3.12. The company’s stock had a trading volume of 6,725,830 shares, compared to its average volume of 5,961,503. The stock’s 50-day moving average is $3.77 and its two-hundred day moving average is $6.89. United States Antimony has a 52-week low of $2.53 and a 52-week high of $12.64. The stock has a market capitalization of $467.27 million, a P/E ratio of -20.81 and a beta of 0.49.

United States Antimony (NYSE:UAMY) last released its quarterly earnings results on Thursday, November 12th. The company reported ($0.06) earnings per share (EPS) for the quarter. The company had revenue of $10.13 million for the quarter. United States Antimony had a negative return on equity of 7.73% and a negative net margin of 55.44%. Equities analysts forecast that United States Antimony will post -0.01 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Joseph A. Carrabba purchased 21,300 shares of the business’s stock in a transaction that occurred on Tuesday, September 1st. The stock was purchased at an average cost of $4.72 per share, with a total value of $100,536.00. Following the completion of the acquisition, the director directly owned 198,401 shares of the company’s stock, valued at approximately $936,452.72. This trade represents a 12.03% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Gary C. Evans purchased 20,000 shares of the business’s stock in a transaction that occurred on Friday, August 28th. The shares were purchased at an average cost of $4.92 per share, with a total value of $98,400.00. Following the completion of the acquisition, the chief executive officer directly owned 2,590,028 shares of the company’s stock, valued at $12,742,937.76. This represents a 0.78% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have bought a total of 62,700 shares of company stock valued at $298,592 over the last quarter. Corporate insiders own 5.50% of the company’s stock.

Hedge Funds Weigh In On United States Antimony

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Geneos Wealth Management Inc. increased its holdings in United States Antimony by 17.9% in the first quarter. Geneos Wealth Management Inc. now owns 9,892 shares of the company’s stock valued at $86,000 after buying an additional 1,500 shares in the last quarter. Farther Finance Advisors LLC boosted its stake in shares of United States Antimony by 65.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 8,545 shares of the company’s stock worth $36,000 after acquiring an additional 3,372 shares in the last quarter. KBC Group NV acquired a new position in United States Antimony during the first quarter worth $31,000. Sanctuary Advisors LLC raised its holdings in United States Antimony by 28.6% during the first quarter. Sanctuary Advisors LLC now owns 18,064 shares of the company’s stock worth $158,000 after purchasing an additional 4,012 shares during the last quarter. Finally, Byrne Asset Management LLC raised its holdings in United States Antimony by 24.1% during the third quarter. Byrne Asset Management LLC now owns 22,620 shares of the company’s stock worth $93,000 after purchasing an additional 4,400 shares during the last quarter. Institutional investors and hedge funds own 9.49% of the company’s stock.

Trending Headlines about United States Antimony

Here are a few of the latest headlines about UAMY:

• Positive Sentiment: Third-quarter revenue rose 16% year over year, to $10.13 million, providing evidence of top-line growth. Read More.
• Neutral Sentiment: HC Wainwright kept its Buy rating but cut its price target from $9.25 to $6.50. The revised target still indicates substantial potential upside from the cited $3.12 price, but the reduction reflects a more cautious outlook. Read More.
• Negative Sentiment: UAMY reported a third-quarter loss of $0.06 per share, wider than the $0.02 loss analysts expected and the $0.04 loss a year earlier. Revenue also missed estimates, while the company’s withdrawal of guidance added uncertainty. These factors were cited in reports of an overnight share decline. Read More. · Read More.

About United States Antimony

United States Antimony Corporation mines, processes and sells antimony and related products. Its offerings include antimony oxide, antimony metal and sodium antimonate, materials used in a range of industrial applications. The company also produces zeolite through its Bear River Zeolite operations in Idaho. Zeolite products are used in applications such as water treatment, agriculture and odor control. Founded in 1968, United States Antimony has processing operations in Montana and Mexico, as well as zeolite operations in Idaho.